Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
Dev Genes Evol ; 215(8): 423-35, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15868204

ABSTRACT

Physical and functional characteristics of the RUNX family of transcription factors are conserved between vertebrates and the Drosophila protein Lozenge. The runt-homology domain responsible for DNA binding and also the C-terminus are both nearly identical between the two proteins. The mammalian and fly proteins heterodimerize with a non-DNA binding partner protein to form a core binding factor essential for gene regulation during cell differentiation. The mammalian protein RUNX1 (AML1/PEBP2alphaB) interacts with the transcription factor Ets-1 to increase DNA binding and transactivation potential. Alternative splicing of the mammalian RUNX1 removes a domain required for this cooperative transactivation. In this work we determine the structure of the lozenge transcription unit and map 21 mutations. We show that the lozenge transcript is alternatively spliced during eye development to remove an Ets interaction domain. Emphasis is placed on Pointed the Drosophila homolog of the vertebrate Ets-1 protein; both Lozenge and Pointed proteins are needed for the activation of prospero expression. We use site-directed mutagenesis and yeast two-hybrid analysis to show that conserved amino acids within the alternate Lozenge exon are important for interaction with Pointed. Furthermore, the ectopic expression of Lozenge is sufficient to rescue Prospero expression in the presence of the Pointed competitor, Yan(ACT). We show that both lozenge isoforms are expressed during eye development and that the relative ratio of the transcripts for the two isoforms is sensitive to changes in Ras activity. We suggest that during eye development, Lozenge isoforms function in divergent roles, either interacting with Pointed on downstream targets or by functioning independently to establish distinct cell fates.


Subject(s)
Alternative Splicing/genetics , DNA-Binding Proteins/genetics , Drosophila Proteins/genetics , Drosophila/embryology , Eye/embryology , Nerve Tissue Proteins/genetics , Proto-Oncogene Proteins c-ets , Proto-Oncogene Proteins/genetics , Transcription Factors/genetics , Amino Acid Sequence , Animals , Binding Sites , Cells, Cultured , DNA-Binding Proteins/metabolism , Drosophila Proteins/metabolism , Eye/metabolism , Models, Biological , Molecular Sequence Data , Mutation , Nerve Tissue Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Protein Binding/genetics , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Structure, Tertiary/genetics , Proto-Oncogene Proteins/metabolism , Transcription Factors/metabolism , Vertebrates/genetics , ras Proteins/metabolism
3.
Bioorg Med Chem Lett ; 14(22): 5599-603, 2004 Nov 15.
Article in English | MEDLINE | ID: mdl-15482932

ABSTRACT

A series of neutral, nonbasic quinolone GnRH antagonists were prepared via Mitsunobu alkylation of protected and unprotected 4-hydroxy quinolone intermediates. The synthetic route was improved by utilization of unique reactivity and convergency afforded by the use of mono and bis-trimethylsilylethyl protected quinolones. Potent neutral GnRH antagonists were identified, including ether and lactam derivatives, that show similar in vitro binding affinity and functional activity as compared to the earlier basic 4-aminoalkyl quinolone series of nonpeptide GnRH antagonists.


Subject(s)
Quinolones/chemical synthesis , Quinolones/pharmacology , Receptors, LHRH/antagonists & inhibitors , Humans , Molecular Structure , Quinolones/chemistry , Receptors, LHRH/chemistry , Structure-Activity Relationship
4.
Dev Genes Evol ; 213(3): 107-19, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12690448

ABSTRACT

Mutations in the lozenge gene of Drosophila melanogaster elicit a pleiotropic set of adult phenotypes, including severe compound eye perturbations resulting from the defective recruitment of photoreceptors R1/6 and R7, cone and pigment cells. In this study, we show that excessive patterned apoptosis is evident at the same developmental stage in these lozenge mutants. In lozenge null mutants, apoptosis occurs prior to lozenge-dependent cell fate specification. A second gene, D-Pax2, genetically interacts with lozenge. Interestingly, D-Pax2 mutants also exhibit increased cell death, but slightly later in development than that in lozenge mutants. Although expression of the caspase inhibitor p35 eliminates death in both lozenge and D-Pax2 mutants, the lozenge mutant eye phenotypes persist because other normal Lozenge functions are still lacking. D-Pax2 eye phenotypes, in contrast, are dramatically altered in a p35 background, because cells that normally differentiate as cone and primary pigment cells are subsequently transformed into secondary pigment cells. This study leads us to propose that Lozenge, aside from its known role in gene regulation of cell-specific transcription factors, is required to contribute to the repression of cell death mechanisms, creating a permissive environment for the survival of undifferentiated cells in early eye development. Lack of lozenge expression increases the likelihood that an undifferentiated cell will initiate its default death program and die prematurely. The ectopic cell death evident in D-Pax2 mutants appears to arise from the cell fate transformation of cone cells into secondary pigment cells, either autonomously or as a result of defective signalling.


Subject(s)
Apoptosis/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Drosophila Proteins/genetics , Drosophila Proteins/physiology , Drosophila melanogaster/genetics , Eye/embryology , Transcription Factors/genetics , Transcription Factors/physiology , Animals , Chromosome Mapping , DNA Primers , Immunohistochemistry , In Situ Hybridization , Models, Biological , Retinal Cone Photoreceptor Cells/embryology , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...